BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22068818)

  • 1. DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma.
    Brait M; Maldonado L; Begum S; Loyo M; Wehle D; Tavora FF; Looijenga LH; Kowalski J; Zhang Z; Rosenbaum E; Halachmi S; Netto GJ; Hoque MO
    Br J Cancer; 2012 Jan; 106(2):414-23. PubMed ID: 22068818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer analysis of the prognostic and immunological role of FKBP4.
    Xiong H; Chen Z; Li Y; Wu Z; Qian D; Chen L; Li Q; Liu H; Chen W; Lin B; Jia Y; Wang C
    Heliyon; 2024 Apr; 10(7):e29098. PubMed ID: 38601662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive tissue markers in testicular germ cell tumors: Immunohistochemical expression of MLH1 and REV-7 proteins.
    Spinos T; Zografos E; Koutsoukos K; Zagouri F; Kosmas C; Driva TS; Goutas D; Gakiopoulou C; Agrogiannis G; Theochari E; Tzavara C; Lazaris AC
    Int Urol Nephrol; 2024 Jun; 56(6):1887-1898. PubMed ID: 38285100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of secretogranin VGF in laryngeal squamous cell carcinoma.
    Gabanella F; Maftei D; Colizza A; Rullo E; Riminucci M; Pasqualucci E; Di Certo MG; Lattanzi R; Possenti R; Corsi A; Greco A; De Vincentiis M; Severini C; Ralli M
    Oncol Lett; 2024 Jan; 27(1):37. PubMed ID: 38108073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Factors and ncRNAs in Testicular Cancer.
    Nuñez-Corona D; Contreras-Sanzón E; Puente-Rivera J; Arreola R; Camacho-Nuez M; Cruz Santiago J; Estrella-Parra EA; Torres-Romero JC; López-Camarillo C; Alvarez-Sánchez ME
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis.
    von Eyben FE; Kristiansen K; Kapp DS; Hu R; Preda O; Nogales FF
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas.
    Inokawa Y; Hayashi M; Begum S; Noordhuis MG; Sidransky D; Califano J; Koch W; Brait M; Westra WH; Hoque MO
    BMC Cancer; 2022 Nov; 22(1):1146. PubMed ID: 36344942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis.
    Medvedev KE; Savelyeva AV; Chen KS; Bagrodia A; Jia L; Grishin NV
    Cancer Inform; 2022; 21():11769351221132634. PubMed ID: 36330202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming Chemotherapy Resistance in Germ Cell Tumors.
    Országhová Z; Kalavska K; Mego M; Chovanec M
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care.
    Nicu AT; Medar C; Chifiriuc MC; Gradisteanu Pircalabioru G; Burlibasa L
    Front Cell Dev Biol; 2022; 10():861995. PubMed ID: 35465311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?
    Ottaviano M; Giunta EF; Rescigno P; Pereira Mestre R; Marandino L; Tortora M; Riccio V; Parola S; Casula M; Paliogiannis P; Cossu A; Vogl UM; Bosso D; Rosanova M; Mazzola B; Daniele B; Palmieri G; Palmieri G
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic alterations as therapeutic targets in Testicular Germ Cell Tumours : current and future application of 'epidrugs'.
    Cardoso AR; Lobo J; Miranda-Gonçalves V; Henrique R; Jerónimo C
    Epigenetics; 2021 Apr; 16(4):353-372. PubMed ID: 32749176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A network-based approach to identify DNA methylation and its involved molecular pathways in testicular germ cell tumors.
    Bo H; Cao K; Tang R; Zhang H; Gong Z; Liu Z; Liu J; Li J; Fan L
    J Cancer; 2019; 10(4):893-902. PubMed ID: 30854095
    [No Abstract]   [Full Text] [Related]  

  • 14. Epigenetic drugs and their molecular targets in testicular germ cell tumours.
    Jostes S; Nettersheim D; Schorle H
    Nat Rev Urol; 2019 Apr; 16(4):245-259. PubMed ID: 30765888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic.
    Lobo J; Gillis AJM; Jerónimo C; Henrique R; Looijenga LHJ
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells.
    Oing C; Verem I; Mansour WY; Bokemeyer C; Dyshlovoy S; Honecker F
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sperm imprinting integrity in seminoma patients?
    Bruno C; Blagoskonov O; Barberet J; Guilleman M; Daniel S; Tournier B; Binquet C; Choux C; Fauque P
    Clin Epigenetics; 2018 Oct; 10(1):125. PubMed ID: 30340650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in DNA methylation profiles by histologic subtype of paediatric germ cell tumours: a report from the Children's Oncology Group.
    Williams LA; Mills L; Hooten AJ; Langer E; Roesler M; Frazier AL; Krailo M; Nelson HH; Bestrashniy J; Amatruda JF; Poynter JN
    Br J Cancer; 2018 Oct; 119(7):864-872. PubMed ID: 30287918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors.
    Chen KS; Fustino NJ; Shukla AA; Stroup EK; Budhipramono A; Ateek C; Stuart SH; Yamaguchi K; Kapur P; Frazier AL; Lum L; Looijenga LHJ; Laetsch TW; Rakheja D; Amatruda JF
    Mol Cancer Ther; 2018 May; 17(5):1079-1089. PubMed ID: 29483210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the molecular aspects associated with testicular germ cell tumors: a review.
    Facchini G; Rossetti S; Cavaliere C; D'Aniello C; Di Franco R; Iovane G; Grimaldi G; Piscitelli R; Muto P; Botti G; Perdonà S; Veneziani BM; Berretta M; Montanari M
    Oncotarget; 2018 Jan; 9(1):1365-1379. PubMed ID: 29416701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.